RESEARCH FOR TRANSMEMBRANE SIGNALING SYSTEM OF EPIDERMAL KERATINOCYTES; INTRACELLULAR FREE CALCIUM AND CELLULAR RESPONSES.
RESEARCH FOR TRANSMEMBRANE SIGNALING SYSTEM OF EPIDERMAL KERATINOCYTES; INTRACELLULAR FREE CALCIUM AND CELLULAR RESPONSES.
批准号:
02670469
负责人:
KOIZUMI Hiroko
金额:
$1.66万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for General Scientific Research (C)
财政年份:
1990
资助国家:
日本
项目状态:
已结题
起止时间:
1990 至 1992
中文摘要
表皮角质形成细胞增殖分化,形成角质层。许多化学介质、激素和多肽刺激角质形成细胞诱导磷脂酰肌醇代谢,改变细胞内游离钙,激活腺苷环化酶反应。我们阐明了缓激肽、凝血酶、P物质、β-肾上腺素、腺苷和组胺诱导细胞内游离钙增加。这些作用是通过合成肌醇1,4,5-三磷酸或腺苷环化酶激活来实现的。显示了钙作为第二信使的重要性。免疫组织化学检测膜骨架蛋白SPECTIN、b-fodrin、4.1蛋白样蛋白的存在,并观察其在角质形成细胞中的分布随培养液中钙离子浓度的变化。报道了一种用二氢罗丹明123检测角质形成细胞产生的过氧化氢的新技术。角质形成细胞跨膜信号系统之间的串扰,以及影响这些信号系统的药物有待研究。角化异常和增殖加速被认为与银屑病的发病密切相关。银屑病中膜信号系统的改变以及治疗皮肤病的药物的作用机制正在研究中。
英文摘要
Epidermal keratinocytes proliferate and differentiate to make stratum corneum. Many chemical mediators, hormones and peptides stimulate keratinocytes to induce phosphophatidylinositol metabolism, alteration of intracellular free calcium, adenylate cyclase response activation. We elucidated that bradykinin, thrombin, substance P, beta-adrenarin, adenosine, and histamine induce increase of intracellular free calcium. These effects are mediated with synthesis of inositol 1,4,5-trisphosphate or adenylate cyclase activation. The importance of calcium as a second messenger is shown. Presence of membrane skeleton proteins such as spectrin, b-fodrin, 4.1 protein like proteins were detected immunologically and the alteration of their distribution in cultured keratinocytes were observed with the change of calcium concentration of the medium. A new technique was reported to detect peroxide produced from keratinocytes using dihydrorhodamine 123.Cross-talk among transmembrane signaling systems in keratinocytes, and drugs to influence these systems should be investigated. Abnormal keratinization and acceleration of proliferation are considered to closely realt to pathogenesis of psoriasis. The alteration of membrane signaling systems in psoriasis and the action mechanisms of the drugs used in therapy of skin diseases are under investigation.
期刊论文(29)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
KOIZUMI H.: "Adenosine deaminase activity in serum of patients with psoriasis,mycosis fungoides,and adult T ccll leukemia." Acta Dermatovenereologica(Stockh). 72. 410-412 (1992)
KOIZUMI H.:“银屑病、蕈样肉芽肿和成人 Tccll 白血病患者血清中的腺苷脱氨酶活性。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
小泉 洋子: "角化異常とレチノイド." FRAGRANCE JOURNAL.20. 26-31 (1992)
小泉洋子:“角化不良和类维生素A。”《香水杂志》26-31 (1992)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Shimizu T, Takakuwa Y, Koizumi H, Ishibashi T, Ohkawara A: "Immunoreactive analogues of erythrocyte ankyrin in human epidermal keratinocyte." Archives of Dermmatological Research.
Shimizu T、Takakuwa Y、Koizumi H、Ishibashi T、Ohkawara A:“人表皮角质形成细胞中红细胞锚蛋白的免疫反应类似物。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
小泉 洋子: "表皮細胞情報伝達系とカルシウム" 皮膚病診療. 14. (1992)
小泉洋子:“表皮细胞信号转导系统和钙”皮肤病理学 14。(1992)
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
小泉 洋子: "Protein kinase C." 皮膚科の臨床.
小泉洋子:“蛋白质激酶 C”。临床皮肤病学。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 26 条
Important conditions for creating system of the separate representation of children in child protecting proceedings
-
批准号:19730368
-
项目类别:Grant-in-Aid for Young Scientists (B)
-
资助金额:$1.38万
-
财政年份:2007
-
负责人:KOIZUMI Hiroko
-
依托单位:
Transmembrane signaling system concerning super oxide production
-
批准号:08670937
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.47万
-
财政年份:1996
-
负责人:KOIZUMI Hiroko
-
依托单位:
RESEARCH FOR TRANSMEMBRANE SIGNALING SYSTEM OF EPIDERMAL KERATINOCYTES ; INTRACELLULAR FREE CALCIUM AND PROTEIN KINASE C.
-
批准号:05670717
-
项目类别:Grant-in-Aid for General Scientific Research (C)
-
资助金额:$1.41万
-
财政年份:1993
-
负责人:KOIZUMI Hiroko
-
依托单位:
国内基金
海外基金
Calcium/NFAT/GLUT3通路调控糖酵解代谢在CAR-T细胞耗竭中的作用和机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:张明明
-
依托单位:
miR-30调控Calcium/Calcineurin通路在慢性肾脏病心肌保护中的作用
-
批准号:81670699
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2016
-
负责人:郑春霞
-
依托单位:
水稻OsCAS(Calcium-sensing Receptor)基因的功能分析
-
批准号:30900771
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2009
-
负责人:赵昕
-
依托单位: